Skip to Main content Skip to Navigation
Journal articles

Thiophenecarboxamide Derivatives Activated by EthA Kill Mycobacterium tuberculosis by Inhibiting the CTP Synthetase PyrG

Abstract : To combat the emergence of drug-resistant strains of Mycobacterium tuberculosis, new antitubercular agents and novel drug targets are needed. Phenotypic screening of a library of 594 hit compounds uncovered two leads that were active against M. tuberculosis in its replicating, non-replicating, and intracellular states: compounds 7947882 (5-methyl-N-(4-nitrophenyl)thiophene-2-carboxamide) and 7904688 (3-phenyl-N-[(4-piperidin-1-ylphenyl)carbamothioyl]propanamide). Mutants resistant to both compounds harbored mutations in ethA (rv3854c), the gene encoding the monooxygenase EthA, and/or in pyrG (rv1699) coding for the CTP synthetase, PyrG. Biochemical investigations demonstrated that EthA is responsible for the activation of the compounds, and by mass spectrometry we identified the active metabolite of 7947882, which directly inhibits PyrG activity. Metabolomic studies revealed that pharmacological inhibition of PyrG strongly perturbs DNA and RNA biosynthesis, and other metabolic processes requiring nucleotides. Finally, the crystal structure of PyrG was solved, paving the way for rational drug design with this newly validated drug target.
Complete list of metadata

https://hal-pasteur.archives-ouvertes.fr/pasteur-03096090
Contributor : Marie de Tarragon <>
Submitted on : Monday, January 4, 2021 - 7:18:21 PM
Last modification on : Wednesday, June 2, 2021 - 4:27:22 PM

Links full text

Identifiers

Collections

Citation

Giorgia Mori, Laurent Chiarelli, Marta Esposito, Vadim Makarov, Marco Bellinzoni, et al.. Thiophenecarboxamide Derivatives Activated by EthA Kill Mycobacterium tuberculosis by Inhibiting the CTP Synthetase PyrG. Chemistry and Biology, Elsevier, 2015, 22 (7), pp.917-927. ⟨10.1016/j.chembiol.2015.05.016⟩. ⟨pasteur-03096090⟩

Share

Metrics

Record views

85